Although high-risk HPV is an important oncogenic factor in the development of HNSCC, our clinical research affirmed that survival months increase with SOCS1 expression in same-HPV-status HNSCC, which matches the results we described above. This evidence concerns the gene SOCS1 and head and neck squamous cell carcinoma.